| I-MabBiopharma |
TJM2 |
Jielun Zhu (2020) |
| Medicago |
Virus Like Particle (unnamed) |
(https://www.com/en/pipeline/medicago) |
| Airway Therapeutics |
recombinant protein named AT-100 |
(https://www.co.uk/news-releases/airway-therapeutics-announces-filing-with-nih-to-evaluate-at-100-as-a-therapy-for-novel-coronavirus-821624689.htmlprnewswire) |
| Tiziana Life Sciences |
TZLS-501 |
(https://www..com/story/uk-biotech-tiziana-life-sciences-says-its-tzls-501-may-be-of-use-in-treating-coronavirus-2020-03-11marketwatch) |
| OyaGen |
OYA1 |
(https://spectrumlocalnews.com/nys/rochester/coronavirus/2020/03/12/oyagen-lab-discovers-compound-that-they-believe-could-help-with-the-covid-19-) |
| BeyondSpring |
BPI-002 |
(https://www.com/markets/mergers-and-acquisitions/beyondspring-looks-to-future-after-ipo-pipe-launch-14308176thestreet) |
| Altimmune |
Unnamed intranasal coronavirus vaccine |
(https://biobuzz.io/altimmune-becomes-the-second-maryland-based-biotech-advance-potential-coronavirus-covid-19-vaccine/) |
| Inovio Pharmaceuticals |
INO-4700 |
(https://www.com/investing/2020/03/15/better-coronavirus-stock-inovio-pharmaceuticals-vs.aspxfool) |
| Inovio Pharmaceuticals and Beijing Advaccine Biotechnology |
INO-4800 |
(https://www.com/investing/2020/03/15/better-coronavirus-stock-inovio-pharmaceuticals-vs.aspxfool) |
| Algernon Pharmaceuticals |
NP-120 (Ifenprodil) |
(https://www.-technology.com/news/covid-19-aj-vaccines-algernon-drug/pharmaceutical) |
| University of British Columbia and APEIRON Biologics |
APN01 |
(https://www.com/news/ubc-apeiron-biologics-covid-19-trial/clinicaltrialsarena) |
| National Institute of Allergy and Infectious Diseases |
mRNA-1273 vaccine |
(https://www.com/releases/2020/03/200317150116.htmsciencedaily) |
| MIGAL Research Institute |
Infectious Bronchitis Virus (IBV) vaccine |
(http://www.org.il/Migal.covidmigal) |
| Tonix Pharmaceuticals |
TNX-1800 |
(https://www.-technology.com/news/tonix-pharmaceuticals-covid-19-vaccine/pharmaceutical) |
| Innovation Pharmaceuticals |
Brilacidin |
(https://www.com/article/releases/innovation-pharmaceuticals-brilacidin-to-be-researched-as-possible-novel-coronavirus-covid-19-vaccine-brilacidin-now-being-tested-as-drug-and-vaccine-at-different-institutions/biospace) |
| Clover Biopharmaceuticals |
A recombinant subunit vaccine |
(http://www.com/news/gsk_recruits_clover_biopharmaceuticals_in_latest_coronavirus_effort_1326917pharmatimes) |
| Vaxart |
Oral recombinant vaccine (unnamed) |
(https://pipelinereview.com/index.php/2020020273689/Vaccines/Vaxart-Announces-Initiation-of-Coronavirus-Vaccine-Program.html) |
| CytoDyn |
Leronlimab |
(https://www.com/newsroom/press-releases/detail/392/-files-ind-and-protocol-for-phase-2-clinical-trialcytodyncytodyn) |
| LineaRx and Takis Biotech |
Linear DNA Vaccine |
(https://adnas.com/coronoavirus-applied-dna-linearx-takis-biotech-vaccine/) |
| Bioxytran |
BXT-25 |
(https://www.-technology.com/news/bioxytran-coronavirus-patients-treatment/pharmaceutical) |
| Novavax |
MERS CoV vaccine |
(https://ir.com/news-releases/news-release-details/-advances-development-novel-covid-19-vaccinenovavaxnovavax) |
| Gilead Sciences |
Remdesivir (GS-5734) |
(https://www.com/2020/03/16/remdesivir-surges-ahead-against-coronavirus/statnews) |
| Roche |
Actemra |
(https://www.-technology.com/news/roche-actemra-coronavirus-complications/pharmaceutical) |
| BiocrystPharma |
Galidesivir |
(https://com/article/4331827-biocryst-pharmaceuticals-multiple-value-drivers-coronavirus-kickerseekingalpha) |
| Lattice Biologics |
AmnioBoost |
(https://www.-technology.com/news/can-fite-lattice-biologics-covid-19-treatments/pharmaceutical) |
| Pfizer |
Unnamed |
(https://www.aa.com.tr/en/health/pfizer-biontech-jointly-work-on-coronavirus-vaccine/1769465) |
| ZydusCadila |
Unnamed DNA Vaccine |
(https://www.com/investing/2020/03/12/biogen-and-vir-biotechnology-to-collaborate-to-fin.aspxfool) |
| Biogen and Vir Biotechnology |
Monoclonal antibodies |
(https://www.com/article/india-s-zydus-joins-fight-against-novel-coronavirusthepharmaletter) |
| Genentech (Roche group) |
Actemra® (tocilizumab) |
(https://www.com/investing/2020/03/12/biogen-and-vir-biotechnology-to-collaborate-to-fin.aspxfool) |
